tiprankstipranks
Trending News
More News >
Procaps Group, S.A. (PROCF)
:PROCF
Advertisement

Procaps Group (PROCF) Price & Analysis

Compare
34 Followers

PROCF Stock Chart & Stats


PROCF FAQ

What was Procaps Group, S.A.’s price range in the past 12 months?
Procaps Group, S.A. lowest stock price was $0.01 and its highest was $3.77 in the past 12 months.
    What is Procaps Group, S.A.’s market cap?
    Procaps Group, S.A.’s market cap is $57.60M.
      When is Procaps Group, S.A.’s upcoming earnings report date?
      Procaps Group, S.A.’s upcoming earnings report date is May 08, 2025 which is 97 days ago.
        How were Procaps Group, S.A.’s earnings last quarter?
        Currently, no data Available
        Is Procaps Group, S.A. overvalued?
        According to Wall Street analysts Procaps Group, S.A.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Procaps Group, S.A. pay dividends?
          Procaps Group, S.A. does not currently pay dividends.
          What is Procaps Group, S.A.’s EPS estimate?
          Procaps Group, S.A.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Procaps Group, S.A. have?
          Procaps Group, S.A. has 2,303,865,200 shares outstanding.
            What happened to Procaps Group, S.A.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Procaps Group, S.A.?
            Currently, no hedge funds are holding shares in PROCF

            Company Description

            Procaps Group, S.A.

            Union Acquisition Corp II is a blank check company.

            Procaps Group (PROCF) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            Brainsway
            Annexon Biosciences
            TriSalus Life Sciences
            Terns Pharmaceuticals
            Third Harmonic Bio, Inc.

            Ownership Overview

            0.03%<0.01%99.99%
            Insiders
            <0.01% Other Institutional Investors
            99.99% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis